Written on Mar, 10, 2022 by in
Written on Oct, 14, 2021 by in

Tempo Bioscience is featured as the Cover Story in the 2021 Top10 Biotech Startups by Pharma Tech Outlook. Click here for the digital issue.

Continue Reading...
Written on Apr, 10, 2019 by in

Tempo Bioscience Expands Patient-Relevant iPSC-Derived Cell Models

  • Tempo-iSchwann™    Human iPSC-derived Schwann Cells
  • Tempo-iCardio™        Human iPSC-derived Cardiomyocytes
  • Tempo-iKidneyPod™ Human iPSC-derived Kidney Proximal Tubules & Podocytes 3D Spheroids
  • Tempo-iMono™          Human iPSC-derived CD14+ Monocytes
  • Tempo-iPhago™         Human iPSC-derived Phagocytes

(Announcement via BusinessWire here)

Continue Reading...